Dr. Homood Moqbel As Sobeai is an associate professor of Pharmacogenomics and Molecular Cancer at the Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. Dr. As Sobeai serves as vice dean for graduate studies and scientific research at the College of Pharmacy, King Saud University. Dr. As Sobeai earned his bachelor's degree from the College of Pharmacy, King Saud University, in 2009. He pursued his graduate education at Nova Southeastern University, Fort Lauderdale, Florida, USA. He was awarded his Ph.D. in pharmaceutical sciences, with an emphasis on molecular medicine and pharmacogenomics in 2017.
Currently, Dr. As Sobeai is involved in several dry and wet lab research projects, focusing on identifying novel therapeutics to overcome chemotherapy resistance in cancer therapy, studying the role of senescence in cancer, and screening for genetic and epigenetic factors driving cancer progression and treatment. Dr. As Sobeai has generated work that has been published in respected journals and presented at national and international scientific meetings.
The course deals with the integrated principles and practices of biostatistics as applied to pharmaceutical sciences research. The course covers descriptive and inferential statistics. Topics…
This course introduces students to the principles of pharmacogenomics, protein and nucleic acids synthesis, regulations, functions, and their crucial roles in normal and pathological functions. It…
Toxicogenomics is a subdiscipline of pharmacology that studies the impact of xenobiotics (including drugs) on gene and protein activity. This Ph.D.'s course covers the basic principle of…